Borsini F - Search Results

1

Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance task.

Pitsikas N, Borsini F. Pitsikas N, et al. Among authors: borsini f. Eur J Pharmacol. 1996 Sep 12;311(2-3):115-9. doi: 10.1016/0014-2999(96)00586-9. Eur J Pharmacol. 1996. PMID: 8891590

2

DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in rats.

Brambilla A, Ghiorzi A, Pitsikas N, Borsini F. Brambilla A, et al. Among authors: borsini f. J Pharm Pharmacol. 1993 Sep;45(9):841-3. doi: 10.1111/j.2042-7158.1993.tb05698.x. J Pharm Pharmacol. 1993. PMID: 7903377

3

Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task.

Pitsikas N, Brambilla A, Borsini F. Pitsikas N, et al. Among authors: borsini f. Pharmacol Biochem Behav. 1994 Jan;47(1):95-9. doi: 10.1016/0091-3057(94)90116-3. Pharmacol Biochem Behav. 1994. PMID: 8115433

4

DAU 6215, a novel 5-HT3 receptor antagonist, improves performance in the aged rat in the Morris water maze task.

Pitsikas N, Brambilla A, Borsini F. Pitsikas N, et al. Among authors: borsini f. Neurobiol Aging. 1993 Nov-Dec;14(6):561-4. doi: 10.1016/0197-4580(93)90039-e. Neurobiol Aging. 1993. PMID: 8295658

5

Different effects of tropisetron and ondansetron in learning and memory paradigms.

Pitsikas N, Borsini F. Pitsikas N, et al. Among authors: borsini f. Pharmacol Biochem Behav. 1997 Apr;56(4):571-6. doi: 10.1016/s0091-3057(96)00516-3. Pharmacol Biochem Behav. 1997. PMID: 9130279

6

The adenosine A1 receptor antagonist BIIP 20 counteracts scopolamine-induced behavioral deficits in the passive avoidance task in the rat.

Pitsikas N, Borsini F. Pitsikas N, et al. Among authors: borsini f. Eur J Pharmacol. 1997 Jun 5;328(1):19-22. doi: 10.1016/s0014-2999(97)83021-x. Eur J Pharmacol. 1997. PMID: 9203562

7

Behavioral effects of flibanserin (BIMT 17).

Borsini F, Brambilla A, Grippa N, Pitsikas N. Borsini F, et al. Pharmacol Biochem Behav. 1999 Sep;64(1):137-46. doi: 10.1016/s0091-3057(99)00072-6. Pharmacol Biochem Behav. 1999. PMID: 10495008

8

Effects of cerestat and NBQX on functional and morphological outcomes in rat focal cerebral ischemia.

Pitsikas N, Brambilla A, Besozzi C, Bonali P, Fodritto F, Grippa N, Scandroglio A, Borsini F. Pitsikas N, et al. Among authors: borsini f. Pharmacol Biochem Behav. 2001 Mar;68(3):443-7. doi: 10.1016/s0091-3057(00)00469-x. Pharmacol Biochem Behav. 2001. PMID: 11325397

9

Effect of the 5-hydroxytryptamine3 receptor antagonist itasetron (DAU 6215) on (+)-N-allylnormetazocine-induced dopamine release in the nucleus accumbens and in the corpus striatum of the rat: an in vivo microdialysis study.

Volonté M, Ceci A, Borsini F. Volonté M, et al. Among authors: borsini f. J Pharmacol Exp Ther. 1995 Oct;275(1):358-67. J Pharmacol Exp Ther. 1995. PMID: 7562571

10

Evidence that imipramine activates 5-HT1C receptor function.

Borsini F, Cesana R, Vidi A, Mennini T. Borsini F, et al. Eur J Pharmacol. 1991 Oct 22;203(3):359-63. doi: 10.1016/0014-2999(91)90891-s. Eur J Pharmacol. 1991. PMID: 1773822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters